IPSEN’s 1‑Million Share Buyback Boosts EPS While Preserving LiquidityIPSEN’s week‑ending 28 Aug 2026 share repurchase: 1 M shares at €35, boosting EPS while preserving €1.2 B cash for R&D, patent cliffs and future M&A.IPSEN Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Lisa Martinez 02/09/2026, 04:08 4 minutes to read
IPSEN Executes 6.85 M Share Repurchases in July – Impact, Risks & Market SignalsIPSEN’s week‑long share buy‑back, 20‑26 July 2026, saw 6.85 m shares repurchased across Paris and Luxembourg, boosting EPS modestly while showcasing regulatory transparency and aggressive shareholder value tactics.IPSEN Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Daniel Carter 29/07/2026, 00:22 4 minutes to read